Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2001 Jul;77(909):447–450. doi: 10.1136/pmj.77.909.447

Quadruple therapy for symptomatic spontaneous duodenal ulcer disease

M Bateson 1
PMCID: PMC1760969  PMID: 11423595

Abstract

AIM—To investigate Helicobacter pylori eradication in duodenal ulcer patients with a new regimen, lansoprazole 30 mg daily for one or four weeks plus twice daily tetracycline 500 mg, clarithromycin 250 mg, and metronidazole 400 mg.
BACKGROUND—Spontaneous duodenal ulcer is regularly associated with H pylori, and permanent cure follows eradication of this bacterium. Numerous treatments have been proposed and none is ideal, possibly because of primary or acquired antibiotic resistance. Quadruple regimens with proton pump inhibitor therapy and three antibiotics offer promise as the most effective therapy.
METHODS—From November 1995 all patients with spontaneous duodenal ulcer were offered quadruple therapy. A month after completion a carbon 14 urea breath test (UBT) was performed. Sensitivity of H pylori to the antibiotics used was tested in 1992-3, 1996, and 1999.
RESULTS—A total of 331 patients were treated; 313 attended for a UBT, of which 299 were negative (95.5%). Of those patients who had an endoscopy with positive urease test immediately before treatment, 95/101 (94.0%) on lansoprazole for one week and 116/121 (95.8%) on lansoprazole for four weeks had a negative UBT. H pylori antibiotic sensitivity did not change.
CONCLUSION—This regimen produced some of the best results yet seen and may be generally recommended as first line therapy.


Keywords: Helicobacter pylori; duodenal ulcer

Full Text

The Full Text of this article is available as a PDF (114.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón T., Domingo D., López-Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents. 1999 Jun;12(1):19–26. doi: 10.1016/s0924-8579(99)00051-5. [DOI] [PubMed] [Google Scholar]
  2. Bateson M. C., Diffey B. L. Improving management of duodenal ulcer disease. Postgrad Med J. 1997 Nov;73(865):717–719. doi: 10.1136/pgmj.73.865.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bateson M. C., Winn G., Ahmad F. Sensitivity of Helicobacter pylori to metronidazole. Eur J Cancer Prev. 1997 Jun;6(3):300–302. doi: 10.1097/00008469-199706000-00008. [DOI] [PubMed] [Google Scholar]
  4. Bell G. D., Powell K., Burridge S. M., Pallecaros A., Jones P. H., Gant P. W., Harrison G., Trowell J. E. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther. 1992 Aug;6(4):427–435. doi: 10.1111/j.1365-2036.1992.tb00556.x. [DOI] [PubMed] [Google Scholar]
  5. Borody T. J., Andrews P., Fracchia G., Brandl S., Shortis N. P., Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut. 1995 Oct;37(4):477–481. doi: 10.1136/gut.37.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breuer T., Kim J. G., Gurer I. E., Graham D. P., Osato M., Genta R. M., Graham D. Y. Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther. 1997 Jun;11(3):523–527. doi: 10.1046/j.1365-2036.1997.00173.x. [DOI] [PubMed] [Google Scholar]
  7. Cederbrant G., Kahlmeter G., Ljungh A. The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother. 1993 Jan;31(1):65–71. doi: 10.1093/jac/31.1.65. [DOI] [PubMed] [Google Scholar]
  8. Dickey W., Kenny B. D., McConnell J. B. Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther. 1996 Jun;10(3):289–293. doi: 10.1111/j.0953-0673.1996.00289.x. [DOI] [PubMed] [Google Scholar]
  9. Goddard A. F., Logan R. P. Review article: urea breath tests for detecting Helicobacter pylori. Aliment Pharmacol Ther. 1997 Aug;11(4):641–649. doi: 10.1046/j.1365-2036.1997.00206.x. [DOI] [PubMed] [Google Scholar]
  10. Harris A. W., Misiewicz J. J., Bardhan K. D., Levi S., O'Morain C., Cooper B. T., Kerr G. D., Dixon M. F., Langworthy H., Piper D. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Aliment Pharmacol Ther. 1998 Aug;12(8):741–745. doi: 10.1046/j.1365-2036.1998.00362.x. [DOI] [PubMed] [Google Scholar]
  11. Hirschl A. M., Hirschl M. M., Rotter M. L. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother. 1993 Jul;32(1):45–49. doi: 10.1093/jac/32.1.45. [DOI] [PubMed] [Google Scholar]
  12. Hosking S. W., Ling T. K., Yung M. Y., Cheng A., Chung S. C., Leung J. W., Li A. K. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992 Aug 29;305(6852):502–504. doi: 10.1136/bmj.305.6852.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Houben M. H., van de Beek D., Hensen E. F., de Craen A. J., Rauws E. A., Tytgat G. N. A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther. 1999 Aug;13(8):1047–1055. doi: 10.1046/j.1365-2036.1999.00555.x. [DOI] [PubMed] [Google Scholar]
  14. Logan R. P., Bardhan K. D., Celestin L. R., Theodossi A., Palmer K. R., Reed P. I., Baron J. H., Misiewicz J. J. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther. 1995 Aug;9(4):417–423. doi: 10.1111/j.1365-2036.1995.tb00400.x. [DOI] [PubMed] [Google Scholar]
  15. McColl K. E., el-Nujumi A., Murray L., el-Omar E., Gillen D., Dickson A., Kelman A., Hilditch T. E. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut. 1997 Mar;40(3):302–306. doi: 10.1136/gut.40.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McFarland R. J., Bateson M. C., Green J. R., O'Donoghue D. P., Dronfield M. W., Keeling P. W., Burke G. J., Dickinson R. J., Shreeve D. R., Peers E. M. Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology. 1990 Feb;98(2):278–283. doi: 10.1016/0016-5085(90)90815-i. [DOI] [PubMed] [Google Scholar]
  17. Okada M., Nishimura H., Kawashima M., Okabe N., Maeda K., Seo M., Ohkuma K., Takata T. A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome. Aliment Pharmacol Ther. 1999 Jun;13(6):769–774. doi: 10.1046/j.1365-2036.1999.00551.x. [DOI] [PubMed] [Google Scholar]
  19. Savarino V., Bisso G., Pivari M., Zentilin P., Bilardi C., Dulbecco P., Mele M. R., Tracci D., Vigneri S. Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther. 2000 Mar;14(3):291–297. doi: 10.1046/j.1365-2036.2000.00721.x. [DOI] [PubMed] [Google Scholar]
  20. Sieg A., Sellinger M., Schlauch D., Hörner M., Fuchs W. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. Aliment Pharmacol Ther. 1999 Jul;13(7):865–868. doi: 10.1046/j.1365-2036.1999.00540.x. [DOI] [PubMed] [Google Scholar]
  21. Ström M., Sörberg M., Jönsson K. A. Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori. Aliment Pharmacol Ther. 1997 Apr;11(2):311–316. doi: 10.1046/j.1365-2036.1997.139315000.x. [DOI] [PubMed] [Google Scholar]
  22. Walt R. P. Metronidazole-resistant H pylori--of questionable clinical importance. Lancet. 1996 Aug 24;348(9026):489–490. doi: 10.1016/s0140-6736(05)64665-x. [DOI] [PubMed] [Google Scholar]
  23. de Boer W. A., Tytgat G. N. Regular review: treatment of Helicobacter pylori infection. BMJ. 2000 Jan 1;320(7226):31–34. doi: 10.1136/bmj.320.7226.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van Zwet A. A., Thijs J. C., de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother. 1995 Jan;39(1):250–252. doi: 10.1128/aac.39.1.250. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES